Mortalidad a 30 días posterior a la administración de quimioterapia sistémica en una unidad oncológica regional
Mortality within 30 days of receiving systemic chemotherapy at a regional oncology unit
| dc.creator | Pulgar-Boin, Dahiana A. | |
| dc.creator | Yáñez B., Nicolás | |
| dc.creator | Ortega Gonzales, Francisco | |
| dc.date | 2023-01-04T19:24:40Z | |
| dc.date | 2023-01-04T19:24:40Z | |
| dc.date | 2019 | |
| dc.date.accessioned | 2024-05-02T20:30:19Z | |
| dc.date.available | 2024-05-02T20:30:19Z | |
| dc.identifier | http://repositorio.ucm.cl/handle/ucm/4344 | |
| dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/9274595 | |
| dc.description | Background: The use of systemic chemotherapy has survival and palliation benefits in oncological patients. Mortality at 30 days after the administration of systemic chemotherapy is considered as a quality and safety indicator of oncological patient care. The international mortality threshold is 5%, which is the figure used to compare institutions. Aim: To assess mortality at 30 days after the administration of ambulatory systemic chemotherapy in a regional referral center in adult cancer patients. Material and Methods: Retrospective observational study of patients receiving ambulatory systemic chemotherapy in the oncology service of a regional public hospital during 2018. The 30-day mortality rate was calculated. Demographic characteristics, baseline disease and the treatment received were recorded. Results: During the study period, 690 patients received ambulatory systemic chemotherapy. Chemotherapy was palliative in 76% of patients and 53% received a first line treatment. Seventeen (2.5%) died within 30 days of treatment administration. Nine deaths (52.9%) were definitely related to treatment and sepsis was the most frequent cause. Conclusions: Our mortality rates are similar to international data. This type of audit reviews local outcomes and identifies factors contributing to mortality aiming to improve standards of care. | |
| dc.language | es | |
| dc.rights | Atribución-NoComercial-SinDerivadas 3.0 Chile | |
| dc.rights | http://creativecommons.org/licenses/by-nc-nd/3.0/cl/ | |
| dc.source | Revista Médica de Chile, 147(7), 887-890 | |
| dc.subject | Antineoplastic agents | |
| dc.subject | Benchmarking | |
| dc.subject | Mortality | |
| dc.title | Mortalidad a 30 días posterior a la administración de quimioterapia sistémica en una unidad oncológica regional | |
| dc.title | Mortality within 30 days of receiving systemic chemotherapy at a regional oncology unit | |
| dc.type | Article |